Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07721467) titled 'Neuroplasticity Enhancement From Cognitive Training Reinforced by Psilocybin' on July 22.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Other. Masking: None (Open Label).

Primary Sponsor: National Institute on Aging (NIA)

Condition: Alzheimer's Disease

Intervention: Drug: Psilocybin

Recruitment Status: Not recruiting

Phase: Phase 2

Date of First Enrollment: October 1, 2026

Target Sample Size: 200

Countries of Recruitment: United States

To know more, visit https://clinicaltrials.gov/study/NCT07721467

Disclaimer: Curated by HT ...